Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2,920.9390 USD
−6.99 M USD
45.72 K USD
582.37 K
About Aclarion, Inc.
Sector
Industry
CEO
Brent Ness
Website
Headquarters
Broomfield
Founded
2008
ISIN
US6551871105
FIGI
BBG016Z2HS66
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
Displays a symbol's price movements over previous years to identify recurring trends.